Nutritional compositions and methods for promoting cognitive development

US10945446B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10945446-B2
Application numberUS-202016776777-A
CountryUS
Kind codeB2
Filing dateJan 30, 2020
Priority dateJul 10, 2015
Publication dateMar 16, 2021
Grant dateMar 16, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method for enhancing cognitive development in a pediatric subject involving administering to the subject a nutritional composition which includes up to 7 g/100 Kcal of a fat or lipid; up to 5 g/100 Kcal of a protein or protein equivalent source; 0.25 g/100 Kcal to 16 g/100 Kcal of buttermilk; 5 mg/100 Kcal to 90 mg/100 Kcal of a source of long chain polyunsaturated fatty acid; and 0.015 g/100 Kcal to 1.5 g/100 Kcal of a prebiotic.

First claim

Opening claim text (preview).

What is claimed is: 1. A nutritional composition comprising: up to 7 g/100 Kcal of a fat or lipid; up to 5 g/100 Kcal of a protein source; 0.25 g/100 Kcal to 16 g/100 Kcal of buttermilk, wherein the buttermilk comprises 6 mg/100 Kcal to 300 mg/100 Kcal of phospholipids, 1 mg/100 Kcal to 60 mg/100 Kcal of sphingomyelin, and 0.25 mg/100 Kcal to 7.5 mg/100 Kcal of gangliosides; 5 mg/100 Kcal to 90 mg/100 Kcal of a source of long chain polyunsaturated fatty acids; and a prebiotic. 2. The nutritional composition of claim 1 , wherein the buttermilk is present at a level of about 0.6 g/100 Kcal to about 15 g/100 Kcal. 3. The nutritional composition of claim 1 , wherein the source of long chain polyunsaturated fatty acids comprises docosahexaenoic acid. 4. The nutritional composition of claim 3 , wherein the source of long chain polyunsaturated fatty acids further comprises arachidonic acid. 5. The nutritional composition of claim 4 , wherein the source of long chain polyunsaturated fatty acids is present at a level of about 5 mg/100 Kcal to about 75 mg/100 Kcal. 6. The nutritional composition of claim 5 , wherein the source of long chain polyunsaturated fatty acids comprises docosahexaenoic acid and arachidonic acid at a ratio of arachidonic acid to docosahexaenoic acid of about 1:3 to about 9:1. 7. The nutritional composition of claim 1 , wherein the prebiotic is present at a level of about 0.015 g/100 Kcal to about 1.5 g/100 Kcal. 8. The nutritional composition of claim 1 , wherein the prebiotic comprises polydextrose and galactooligosaccharides. 9. The nutritional composition of claim 7 , wherein the polydextrose and galactooligosaccharides comprise at least about 20% of the prebiotic composition. 10. The nutritional composition of claim 1 , wherein the nutritional composition is an infant formula. 11. A nutritional composition comprising: up to 7 g/100 Kcal of a fat or lipid; up to 5 g/100 Kcal of a protein source; 0.25 g/100 Kcal to 16 g/100 Kcal of buttermilk, wherein the buttermilk comprises 6 mg/100 Kcal to 300 mg/100 Kcal of phospholipids, 1 mg/100 Kcal to 60 mg/100 Kcal of sphingomyelin, and 0.25 mg/100 Kcal to 7.5 mg/100 Kcal of gangliosides; 5 mg/100 Kcal to 90 mg/100 Kcal of a source of long chain polyunsaturated fatty acids; a prebiotic; and lactoferrin. 12. The nutritional composition of claim 11 , wherein the buttermilk is present at a level of 0.6 g/100 Kcal to 15 g/100 Kcal. 13. The nutritional composition of claim 11 , wherein the lactoferrin is present at a level of about 5 mg/100 Kcal to about 300 mg/100 Kcal. 14. The nutritional composition of claim 13 , wherein the lactoferrin is from a non-human source. 15. The nutritional composition of claim 11 , wherein the source of long chain polyunsaturated fatty acids comprises docosahexaenoic acid, arachidonic acid, or a combination thereof. 16. The nutritional composition of claim 15 , wherein the source of long chain polyunsaturated fatty acids is present at a level of about 5 mg/100 Kcal to about 75 mg/100 Kcal. 17. The nutritional composition of claim 16 , wherein the source of long chain polyunsaturated fatty acids comprises docosahexaenoic acid and arachidonic acid at a ratio of arachidonic acid to docosahexaenoic acid of about 1:3 to about 9:1. 18. The nutritional composition of claim 11 , wherein the prebiotic is present at a level of about 0.015 g/100 Kcal to 1.5 g/100 Kcal. 19. The nutritional composition of claim 11 , wherein the prebiotic comprises polydextrose and galactooligosaccharides. 20. The nutritional composition of claim 11 , wherein the nutritional composition is an infant formula.

Assignees

Inventors

Classifications

  • A61K38/482Primary

    Serine endopeptidases (3.4.21) · CPC title

  • Dairy proteins · CPC title

  • Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12 · CPC title

  • using additives (addition of substantially indigestible substances A23L33/21) · CPC title

  • Addition of substantially indigestible substances, e.g. dietary fibres · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10945446B2 cover?
A method for enhancing cognitive development in a pediatric subject involving administering to the subject a nutritional composition which includes up to 7 g/100 Kcal of a fat or lipid; up to 5 g/100 Kcal of a protein or protein equivalent source; 0.25 g/100 Kcal to 16 g/100 Kcal of buttermilk; 5 mg/100 Kcal to 90 mg/100 Kcal of a source of long chain polyunsaturated fatty acid; and 0.015 g/100…
Who is the assignee on this patent?
Mead Johnson Nutrition Co
What technology area does this patent fall under?
Primary CPC classification A61K38/482. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Mar 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).